Quantinuum Inc. (NASDAQ:QNT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and thirteen have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $85.62.
Several equities analysts have recently issued reports on the company. Yorkville Ives started coverage on Quantinuum in a research report on Monday, October 5th. They set an “outperform” rating and a $60.00 price target on the stock. Jefferies Financial Group cut their price objective on Quantinuum from $85.00 to $65.00 and set a “buy” rating for the company in a report on Friday. Sanford C. Bernstein reaffirmed a “hold” rating on shares of Quantinuum in a research note on Wednesday, August 12th. Cantor Fitzgerald decreased their target price on Quantinuum from $90.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday. Finally, JPMorgan Chase & Co. lowered their target price on Quantinuum from $97.00 to $80.00 and set an “overweight” rating on the stock in a report on Friday.
View Our Latest Research Report on Quantinuum
Quantinuum Stock Up 26.0%
NASDAQ QNT opened at $37.57 on Friday. Quantinuum has a 12 month low of $28.31 and a 12 month high of $86.79. The firm has a market capitalization of $9.89 billion and a price-to-earnings ratio of -134.18. The company’s 50 day moving average is $43.41.
Quantinuum (NASDAQ:QNT – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.99) by $0.70. The firm had revenue of $9.05 million during the quarter. Analysts forecast that Quantinuum will post -4.76 EPS for the current year.
Hedge Funds Weigh In On Quantinuum
Several large investors have recently made changes to their positions in QNT. Russell Investments Group Ltd. acquired a new position in shares of Quantinuum in the 3rd quarter worth approximately $97,000. Pier 88 Investment Partners LLC bought a new stake in shares of Quantinuum in the 3rd quarter worth approximately $154,000. Fifth Third Bancorp lifted its stake in Quantinuum by 1,530.2% during the third quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after purchasing an additional 964 shares during the last quarter. State of Wyoming acquired a new stake in Quantinuum during the third quarter valued at approximately $378,000. Finally, Flagship Harbor Advisors LLC acquired a new stake in Quantinuum during the third quarter valued at approximately $206,000.
Quantinuum News Roundup
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
- Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
- Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
- Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results
About Quantinuum
Quantinuum develops quantum computers, software and cybersecurity products for businesses, researchers and government organizations. Its work includes trapped-ion quantum systems, tools for programming and managing quantum applications, and services focused on quantum chemistry and data security.
The company was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum, bringing together quantum hardware and software capabilities. Its offerings include the H-series quantum computers, the TKET software development kit and InQuanto, a platform for quantum chemistry research.
Further Reading
- Five stocks we like better than Quantinuum
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
